CHRS Coherus BioSciences
- 1.220
- -0.040-3.17%
- 1.290
- +0.070+5.74%
Coherus BioSciences News
Coherus BioSciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Rubric Capital Management LP(9.03%),David Rosen(9.03%)
Coherus BioSciences | 10-Q: Q3 2024 Earnings Report
Coherus BioSciences | 8-K: Coherus BioSciences Reports Third Quarter 2024 Financial Results and Provides Business Update
Coherus BioSciences | 8-K: Current report
Coherus BioSciences | UPLOAD: Others
Coherus BioSciences | CORRESP: CORRESP
Coherus BioSciences | UPLOAD: Others
Coherus BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer McMichael Bryan J
Coherus BioSciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Coherus BioSciences | 10-Q: Q2 2024 Earnings Report
Coherus BioSciences | 8-K: Coherus BioSciences Reports Second Quarter 2024 Financial Results and Provides Business Update
Coherus BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer Lanfear Dennis M
Coherus BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer Reider Paul
Coherus BioSciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Temasek Holdings (Private) Limited(4.8%),Fullerton Management Pte Ltd(4.8%), etc.
Coherus BioSciences | 8-K: Current report
Coherus BioSciences | 8-K: Current report
Coherus BioSciences | 4: Statement of changes in beneficial ownership of securities-Director Karachun Rita A
Coherus BioSciences | 3: Initial statement of beneficial ownership of securities-Director Karachun Rita A
Coherus BioSciences | 4: Statement of changes in beneficial ownership of securities-Director Erbez Georgia
Coherus BioSciences | 4: Statement of changes in beneficial ownership of securities-Director Newton Charles W.
Analysis
Price Target
No Data
No Data